We’re excited to share that Xgene Pharmaceutical has announced positive topline results from their late-phase trial of XG005, an innovative non-opioid treatment for post-surgical pain.
Lotus Clinical Research is proud to be featured in an exciting study in collaboration with Evolution Research Group and Gonzaba Medical Group, exploring the cognitive
We are thrilled to share that our own Lance Ballester presented a poster at the Joint Statistical Meetings Annual Conference in Portland, Oregon this past
Lotus collaborated with ERG and Concentric in vocacapsaicin bunionectomy trial The Lotus Team is thrilled to have collaborated with both ERG and Concentric on this
Join us at ASCP to learn how Lotus dependably delivers high-quality CNS clinical trials Lotus Clinical Research is at the American Society of Clinical Psychopharmacology
Celebrating a Decade of Excellence and Innovation in Clinical Research On April 14th, we mark a significant milestone in our journey – a decade dedicated
Join us at ASCPT 2024 to Learn How Lotus Applies Better Science for Superior Results Lotus is gearing up for #ASCPT2024 in beautiful Colorado Springs from March
Placebo Response Mitigation in Pain Clinical Trials If you are attending the Pain Therapeutics Summit in San Diego then do not miss this exciting Pre-Conference
South Rampart Pharma Receives FDA Fast Track Designation NEW ORLEANS – South Rampart Pharma, a clinical-stage biopharmaceutical company targeting the safer treatment of pain, has
Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined
South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial – SRP-001, a novel, non-opioid investigational drug that
We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
